D. Sanglard

Discipline

Psychologie (1) Sciences de l'information et de la communication (1) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (54) Recensions (5)

Type de document

Mémoires, Thèses et HDR (1)

Co-auteur

Date

Date

Source

Source

Mot-clé

résistance (31) Genes (29) Candida (28) Treatment (24) Candida albicans (23) Drug resistance (21) Human beings (20) agent pathogène (19) Expression (19) Example (19) roman (19) Susceptibility (17) thérapie (16) modèle (16) Therapeutics (16) espèce (15) infection (15) Species (15) Infection (15) Infections (14) Yeast (13) Patients (13) Patients (13) levure (12) analyse (12) Mice (12) Cells (12) Antifungal agents (12) Analysis (12) gène (11)

Mot-clé

Development (1) Employment (1) Variation (1) Treatment (1) Clinical pharmacology (1) Sports records (1) Signs and symbols (1) Progress (1) Prediction theory (1) Mycoses (1) Miracles (1) Medical microbiology (1) Liquids (1) Licenses (1) International organization (1) Impact (1) High pressure (Technology) (1) High pressure (Science) (1) Evidence (1) Division (1) Communicable diseases (1) Clinics (1) Candida (1) Breast (1) Blood plasma (1) Athletic ability (1) Use studies (1) Use studies (1) Technique (1) Toxicology (1)

Documents écrit par D. Sanglard (54) | parle de D. Sanglard (1)

Using in vivo transcriptomics and RNA enrichment to identify genes involved in virulence of Candida glabrata.
S. Schrevens et al.
A novel Candida glabrata doxycycline-inducible system for in vitro/in vivo use.
S. Schrevens et al. (24 sept. 2022)
How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
N. Pellaton et al. (2022)
Editorial: Antifungal Resistance: From Molecular to Global Issues.
D. Hagiwara et al. (2022)
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris.
J. Li et al. (22 déc. 2021)
Investigating Candida glabrata Urinary Tract Infections (UTIs) in Mice Using Bioluminescence Imaging.
S. Schrevens et al. (9 oct. 2021)
Aequorin as a Useful Calcium-Sensing Reporter in Candida albicans.
D. Sanglard (20 avr. 2021)
Camphor and Eucalyptol-Anticandidal Spectrum, Antivirulence Effect, Efflux Pumps Interference and Cytotoxicity.
M. Ivanov et al. (6 janv. 2021)
Flavones, Flavonols, and Glycosylated Derivatives-Impact on Candida albicans Growth and Virulence, Expression of CDR1 and ERG11, Cytotoxicity.
M. Ivanov et al. (30 déc. 2020)
New Data on the In Vitro Activity of Fenticonazole against Fluconazole-Resistant Candida Species.
M. Cacaci et al. (17 nov. 2020)
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.
A.T. Coste et al.
Signaling Pathways Governing the Caspofungin Paradoxical Effect in Aspergillus fumigatus.
N. Papon et al. (18 août 2020)
Single yeast cell nanomotions correlate with cellular activity.
RG Willaert et al.
Yeast Nanometric Scale Oscillations Highlights Fibronectin Induced Changes in C. albicans
AC Kohler et al. (21 févr. 2020)
Revealing the astragalin mode of anticandidal action.
M. Ivanov et al. (2020)
Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans.
E. Delarze et al. (2020)
Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis.
VDT Tran et al. (1 juil. 2019)
Link between Heat Shock Protein 90 and the Mitochondrial Respiratory Chain in the Caspofungin Stress Response of Aspergillus fumigatus.
M. Aruanno et al.
Machine Learning Approach for Candida albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
M. Delavy et al. (2019)
Persistence of Candida albicans in the Oral Mucosa Induces a Curbed Inflammatory Host Response That Is Independent of Immunosuppression.
F.R. Kirchner et al. (2019)
Finding the needle in a haystack: Mapping antifungal drug resistance in fungal pathogen by genomic approaches.
D. Sanglard
Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
P. Van Dijck et al. (14 juin 2018)
Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
A. Riat et al.
Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens.
S. Dorsaz et al.
Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.
A. Vella et al. (22 août 2017)

next
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods, [and] Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
A. Pascual (2010)